- Jennifer Wallace, Chair of SFNet’s 40 Under 40 Awards, Encourages Members to Nominate Rising Stars
- Gordon Brothers Completes Big Lots Purchase & Facilitates Going Concern Sale
- eCapital Acquires LSQ to Expand Technology Solutions and Strengthen Market Leadership
- Interview with Kristin Maxwell, Member of SFNet’s Inclusiveness Committee
- Solifi Appoints Corazzi Chief Executive Officer as Hamilton Steps up Into Chairman Role
Huntington Business Credit Closes Credit Facility with Spirit Pharmaceuticals, LLC
August 8, 2022
By Huntington Business Credit
Huntington Business Credit announced it closed a $20,000,000 new credit facility with Spirit Pharmaceuticals, LLC on July 6, 2022. Proceeds of the facility were used to refinance existing indebtedness and provide ongoing working capital growth financing.
Spirit Pharmaceuticals, LLC, headquartered in Ronkonkoma, New York, is a packager and wholesaler of private label over the counter (“OTC”) pharmaceutical products.
Huntington Business Credit provides working capital and term loan facilities to middle market companies for acquisitions, LBO’s, MBO’s recapitalizations, rapid growth, seasonal working capital build-up, and turnaround situations.
